Literature DB >> 19290572

Remedial operation for primary hyperparathyroidism.

Jason D Prescott1, Robert Udelsman.   

Abstract

BACKGROUND: Remedial surgery for patients with persistent or recurrent primary hyperparathyroidism (1 degrees HPT) remains a significant challenge. Cervical reexploration is technically difficult; reoperative neck anatomy is distorted by fibrosis and, as a result, remedial 1 degrees HPT patients carry an increased risk of injury to the recurrent (RLN) and superior laryngeal nerve(s) as well as to normal residual parathyroid tissue. Causative hyperfunctioning parathyroid tissue is also more frequently ectopic in the remedial setting and can thus be difficult to localize.
METHODS: This report assimilates the current data underlying preoperative, intraoperative and postoperative remedial 1 degrees HPT management and presents an evidence-based algorithm for the management of remedial parathyroid disease. Recommendations are graded according to the quality of supporting data using the system initially developed by Sackett (Chest 95:2S-4S, 1989) and subsequently modified by Heinrich et al. (Ann Surg 243:154-168, 2006).
RESULTS: Recent advances in preoperative localization and intraoperative adjuncts have lead to substantial improvements in outcomes after remedial surgery. Preoperative localization techniques, including sestamibi scintigraphy (MIBI), high resolution ultrasound (US), US-guided fine needle aspiration (FNA) and selective venous sampling (SVS), coupled with intraoperative adjuncts such as the rapid parathyroid hormone (PTH) assay have lead to reoperative cure rates as high as 96 percent. Nonetheless, management of remedial 1 degrees HPT varies significantly between surgeons and no formal recommendations standardizing the care of these patients have been published.
CONCLUSIONS: Despite the significant challenges associated with remedial surgery for 1 degrees HPT, excellent outcomes can be reproducibly achieved when proper pre-, intra-, and postoperative management is employed.

Entities:  

Mesh:

Year:  2009        PMID: 19290572     DOI: 10.1007/s00268-009-9962-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  55 in total

1.  Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations.

Authors:  J F Moley; T C Lairmore; G M Doherty; L M Brunt; M K DeBenedetti
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

2.  Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease.

Authors:  Thomas Clerici; Michael Brandle; Jochen Lange; Gerard M Doherty; Paul G Gauger
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

3.  A CASE OF OSTEITIS FIBROSA CYSTICA (OSTEOMALACIA?) WITH EVIDENCE OF HYPERACTIVITY OF THE PARA-THYROID BODIES. METABOLIC STUDY II.

Authors:  W Bauer; F Albright; J C Aub
Journal:  J Clin Invest       Date:  1930-02       Impact factor: 14.808

4.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

5.  Percutaneous ethanol injection into parathyroid adenomas: mid- and long-term results.

Authors:  J P Cercueil; D Jacob; B Verges; P Holtzmann; J M Lerais; D Krause
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

6.  Localization of parathyroid adenomas by selective venous catheterization and radioimmunoassay.

Authors:  R E Reitz; J J Pollard; C A Wang; D J Fleischli; O Cope; T M Murray; L J Deftos; J T Potts
Journal:  N Engl J Med       Date:  1969-08-14       Impact factor: 91.245

7.  Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  Janice L Pasieka; Louise L Parsons; Michael J Demeure; Stuart Wilson; Peter Malycha; Jean Jones; Beth Krzywda
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

8.  Rapid parathyroid hormone analysis during venous localization.

Authors:  Robert Udelsman; John E Aruny; Patricia I Donovan; Lori J Sokoll; Florie Santos; Richard Donabedian; Anthony C Venbrux
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

9.  Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.

Authors:  Jens Bollerslev; Svante Jansson; Charlotte L Mollerup; Jörgen Nordenström; Eva Lundgren; Ove Tørring; Jan-Erik Varhaug; Marek Baranowski; Sylvi Aanderud; Celina Franco; Bo Freyschuss; Gunhild A Isaksen; Thor Ueland; Thord Rosen
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

10.  Persistent and recurrent sporadic primary hyperparathyroidism: histopathology, complications, and results of reoperation.

Authors:  C J Weber; C W Sewell; W C McGarity
Journal:  Surgery       Date:  1994-12       Impact factor: 3.982

View more
  7 in total

Review 1.  Influence of surgical volume on operative failures for hyperparathyroidism.

Authors:  Barbara Zarebczan; Herbert Chen
Journal:  Adv Surg       Date:  2011

2.  Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.

Authors:  Anamika Singh; Masum M Mia; Dasan Mary Cibi; Ashutosh Kumar Arya; Sanjay Kumar Bhadada; Manvendra K Singh
Journal:  J Biol Chem       Date:  2019-04-12       Impact factor: 5.157

3.  Primary hyperparathyroidism: an analysis of failure of parathyroidectomy.

Authors:  A Bagul; H P Patel; D Chadwick; B J Harrison; S P Balasubramanian
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

4.  Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Authors:  T Weber; C Dotzenrath; H Dralle; B Niederle; P Riss; K Holzer; J Kußmann; A Trupka; T Negele; R Kaderli; E Karakas; F Weber; N Rayes; A Zielke; M Hermann; C Wicke; R Ladurner; C Vorländer; J Waldmann; O Heizmann; S Wächter; S Schopf; W Timmermann; D K Bartsch; R Schmidmaier; M Luster; K W Schmid; M Ketteler; C Dierks; P Schabram; T Steinmüller; K Lorenz
Journal:  Langenbecks Arch Surg       Date:  2021-04-21       Impact factor: 3.445

5.  The changing face of reoperative parathyroidectomy: a single-centre comparison of 147 parathyroid reoperations.

Authors:  C Camenzuli; A N DiMarco; K E Isaacs; Y Grant; J Jackson; A Alsafi; C Harvey; T D Barwick; N Tolley; F F Palazzo
Journal:  Ann R Coll Surg Engl       Date:  2020-08-24       Impact factor: 1.891

6.  Minimally invasive parathyroidectomy.

Authors:  Lee F Starker; Annabelle L Fonseca; Tobias Carling; Robert Udelsman
Journal:  Int J Endocrinol       Date:  2011-05-23       Impact factor: 3.257

7.  A 10-year experience in intraoperative parathyroid hormone measurements for primary hyperparathyroidism: a prospective study of 91 previous unexplored patients.

Authors:  M C Neves; M N Ohe; M Rosano; M Abrahão; O Cervantes; M Lazaretti-Castro; J G H Vieira; I S Kunii; R O Santos
Journal:  J Osteoporos       Date:  2012-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.